- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Biomedicines, 9.2021, 9, art. 1254, S. 1-13
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2021
- Creator
-
Elli, Stefano
Bojkova, Denisa
Bechtel, Marco
Vial, Thomas
Boltz, David
Muzzio, Miguel
Peng, Xinjian
Sala, Federico
Cosentino, Cesare
Goy, Andrew
Guerrini, Marco
Müller, Lutz
Cinatl, Jindrich
Margitich, Victor
Velthuis, Aartjan J. W. te
- DOI
-
10.3390/biomedicines9091254
- URN
-
urn:nbn:de:hebis:30:3-692539
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Elli, Stefano
- Bojkova, Denisa
- Bechtel, Marco
- Vial, Thomas
- Boltz, David
- Muzzio, Miguel
- Peng, Xinjian
- Sala, Federico
- Cosentino, Cesare
- Goy, Andrew
- Guerrini, Marco
- Müller, Lutz
- Cinatl, Jindrich
- Margitich, Victor
- Velthuis, Aartjan J. W. te
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2021
Other Objects (12)
Die Entwicklung von Zellkulturen in proteinfreien chemisch volldefinierten Medien : Perspektiven für die Virologie und Biotechnologie
Aprotinin inhibits SARS-CoV-2 replication
Targeting pentose phosphate pathway for SARS-CoV-2 therapy
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles
Lack of antiviral activity of darunavir against SARS-CoV-2
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings
Weltweiter SARS-Alarm : eine neue Seuche auf dem Vormarsch?
Die Entwicklung von Zellkulturen in proteinfreien chemisch volldefinierten Medien : Perspektiven für die Virologie und Biotechnologie
Aprotinin inhibits SARS-CoV-2 replication
Targeting pentose phosphate pathway for SARS-CoV-2 therapy
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles
Lack of antiviral activity of darunavir against SARS-CoV-2
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings
Weltweiter SARS-Alarm : eine neue Seuche auf dem Vormarsch?
Die Entwicklung von Zellkulturen in proteinfreien chemisch volldefinierten Medien : Perspektiven für die Virologie und Biotechnologie
Aprotinin inhibits SARS-CoV-2 replication
Targeting pentose phosphate pathway for SARS-CoV-2 therapy
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles
Lack of antiviral activity of darunavir against SARS-CoV-2
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings